profit from every €100 of sales.

Metrovacesa
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
You pay €31.15 for every €1 of profit it makes in a year.
of earnings would pay off all its debt.
Money in, money out
What Metrovacesa sold, what it kept, and what it did with the cash.
Sales went from €519 million in 2022 to €708 million in 2025, with €56.9 million of profit last year.
Metrovacesa handed back more cash to shareholders than it generated last year.
Metrovacesa vs. similar companies
Metrovacesa grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
Metrovacesa | 31.1× · Expensive | ||
Sun Hung Kai Properties | 17.5× · Fair price | ||
Emaar Properties PJSC | 6.5× · Cheap | ||
China Resources Land | 7.6× · Cheap | ||
CK Asset Holdings | 15.7× · Fair price |
AI analysis
An AI analyst reads Metrovacesa's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 519 | 586 | 654 | 708 | |
| 97 | 128 | 124 | 180 | |
| -8 | 9 | 48 | 81 | |
| -0 | 10 | 54 | 96 | |
| -23 | -21 | 16 | 57 | |
| -0.16 | -0.14 | 0.10 | – | |
| 18.7% | 21.8% | 19.0% | 25.4% | |
| -1.5% | 1.5% | 7.4% | 11.4% | |
| -4.5% | -3.6% | 2.4% | 8.0% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2,514 | 2,533 | 2,414 | 2,258 |
| Cash | 124 | 72 | 84 | 130 |
| Total debt | 348 | 438 | 394 | 404 |
| Total liabilities | 708 | 847 | 817 | 844 |
| 1,806 | 1,685 | 1,597 | 1,414 | |
| 151 | 151 | 152 | – | |
| -0.2% | 0.2% | 2.1% | 3.9% | |
| -1.3% | -1.2% | 1.0% | 4.0% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 211 | 32 | 95 | 217 | |
| – | 1 | – | 0 | |
| 211 | 31 | 95 | 217 | |
| Dividends paid | 230 | 100 | 105 | 239 |
| 21 | – | – | 0 | |
| – | – | – | – |
Valuation
- 31.1×
- –
- –
- 1.1×
- 2.5×
- 8.2×
- 21.4×
- 12.3%
- 3.2%
- 13.5%
Profitability
- 25.4%
- 11.4%
- 8.0%
- –
- 3.9%
- 1.5%
- –
- –
- –
- –
Growth
- +10.9%
- –
- –
- –
- +0.0%
Financial health
- 2.9×
- 0.29
- –
- 4.3×
- 3.59
- –
- –
How it ranks in Real Estate
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
How safe it looks
421.2% of its profit
Room to growStretchedMore than it earns: 110.4%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Metrovacesa
Is Metrovacesa a good stock to buy?
A solid business, but the price is high. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Metrovacesa AI analysis
What does Metrovacesa do?
Metrovacesa S.A. operates as a real estate development company in Spain. The company develops and sells residential and commercial premises, as well as selling land. Metrovacesa S.A. was founded in 1918 and is based in Madrid, Spain. It is in Real Estate - Development, based in Madrid, Spain, with 214 employees.
Does Metrovacesa pay a dividend?
Yes. At today's price the dividend is 13.5% a year. In 2025 it paid out €239 million in dividends.
Is Metrovacesa stock halal?
Yes. Metrovacesa passes our halal screen: its business is permitted and its debt is 23% of its market value, under the 30% limit. How we check
Who are Metrovacesa's competitors?
The largest listed companies in the same industry are Sun Hung Kai Properties, Emaar Properties PJSC, China Resources Land and CK Asset Holdings. The peers table on this page compares their profit, growth and price with Metrovacesa's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.



